1.866.771.8946

Caris Target Now Ordering Information

If this is your first time ordering Caris Target Now, please contact Client Services to set up your Caris client profile.

If you're an existing Caris client and would like to order Caris Target Now, please download and complete the Caris Target Now Requisition Form and fax it – along with the pathology report, patient history and insurance information – to 1.866.479.4925.

Caris Target Now Requisition Form

Tumor Profiling Requisition (Download PDF)


Requisition Form Instructions

Medical Oncology Instructions (Download PDF)

Hospital Staff Instructions (Download PDF)

  1. Complete the Patient, Client and Pathology Information sections of the Requisition Form, as well as listing any additional physicians that need to be copied when the final report is released.
  2. Obtain the insurance/demographic information for the patient. Patient insurance information is required prior to testing.
  3. Document the Specimen Information, including Site, Date and Time of Collection. Also, detail the patient’s current treatment status and past therapies.
  4. Select either the Caris Target Now Comprehensive Profile or individual assay box. A molecular profiling service must be selected in order for testing to be performed.

If submitting a Fresh Specimen:

  1. Attach the patient insurance information, pathology report and clinical history/most recent notes, and fax with the Requisition Form to 1.866.479.4925 before placing in the shipper kit.
  2. Call Caris Target Now Client Services at 1.800.901.5177 to arrange pick-up.

If submitting an Archived Specimen:

  • Collect the patient insurance information, pathology report and clinical history/most recent notes, and fax with the Requisition Form to 1.866.479.4925.
  • Contact your pathology department to request specimen be sent to Caris for molecular profiling.

Caris Client Services will handle all necessary block, slide or fresh tissue coordination with pathology including:

  • Shipment of paraffin block/slide or fresh frozen kits, including pre-paid shipping labels and delivery of dry ice as needed
  • Specimen requirements
  • Follow-up/tracking on specimen receipt
  • Any further authorizations or necessary pathology information

*If a surgical procedure is planned, provide the anticipated specimen information, date and time of procedure and the location/facility information.

Caris Shipper Kits

Shipper kits are available for both Fresh and Archived Specimens. To order, contact clientservices-oncology@carisls.com

  • Paraffin Block/Slide Shipper (Archived Specimens)
  • Formalin Shipper (Fresh Specimens)

Sample Requirements

Sufficient tumor must be present to complete all testing. If you have any questions, please contact Caris Target Now Client Services at 1.800.901.5177, option 2

Formalin-Fixed Paraffin-Embedded (FFPE) Samples

SPECIMEN TYPE SPECIMEN REQUIREMENTS
Fixed Tissue One (1) Formalin-Fixed paraffin-embedded block (FFPE) containing tumor from most recent surgery or biopsy
Unstained Slides Fifty-five (55) unstained, positively charged, unbaked slides from one single paraffin block
Bone Marrow Core or Clot Clot Preferred: Core accepted
  • Core should be decalcified
  • Formalin fixed core and/or clot should be paraffin-embedded
Core Needle Biopsy Four to six (4-6) biopsies paraffin-embedded
  • 18 gauge needle preferred
Malignant Fluids Sufficient volume of fresh pleural/ascitic fluid to produce a 5x5x2mm cell pellet
  • Collect and process within 30 minutes of procurement
  • FORMALIN FIX and paraffin block
  • DO NOT expose to alcohol fixation
Fine Needle Aspirate (FNA) Four to six (4-6) aspirates paraffin-embedded

Formalin Samples

SPECIMEN TYPE SPECIMEN REQUIREMENTS
Fresh Tissue Prepare two or more samples with a minimum thickness of ~3mm (height, width, length) in formalin
Core Needle Biopsy Submit four (4) or more cores in formalin, from 18g needle minimum

Caris Target Now was developed and its performance characteristics were determined by Caris Life Sciences, a medical laboratory CLIA-certified in compliance with the U.S. Clinical Laboratory Amendment Act of 1988 and all relevant U.S. state regulations. It has not been approved by the United States Food and Drug Administration.

“[Cancer treatment] has transformed and I’ve had to transform with it.” – Dr. Waisman

Watch Videos

“I feel so lucky. … Caris Target Now has meant my life.” – Sandy

Watch Videos

Coming Soon


MyCancer.com

Explore cancer biomarkers, signaling pathways and cancer treatment research at CarisTargetNow.com.

MyCancer.com


MyCancer.com

Caris supports MyCancer.com, a new site for cancer patients about molecular profiling, cancer biomarkers and personalized treatment.

Find a Doctor


Find A Doctor

Find a local doctor who can help you determine if Caris Target Now might be right for you.